Nuclear lncRNA CERNA1 enhances the cisplatin-induced cell apoptosis and overcomes chemoresistance via epigenetic activation of BCL2L10 in ovarian cancer
Main Authors: | Rui Xu, Hui Peng, Ning Yang, Zhenping Liu, Wei Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
KeAi Communications Co., Ltd.
2023-01-01
|
Series: | Genes and Diseases |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352304222000125 |
Similar Items
-
Cisplatin for cancer therapy and overcoming chemoresistance
by: Ranmali Ranasinghe, et al.
Published: (2022-09-01) -
Characterization of Dysregulated lncRNA-Associated ceRNA Network Reveals Novel lncRNAs With ceRNA Activity as Epigenetic Diagnostic Biomarkers for Osteoporosis Risk
by: Meijie Zhang, et al.
Published: (2020-03-01) -
Identification of LncRNA Prognostic Markers for Ovarian Cancer by Integration of Co-expression and CeRNA Network
by: Huisheng Liang, et al.
Published: (2021-02-01) -
lncRNA-mediated ceRNA network in bladder cancer
by: Kun Li, et al.
Published: (2023-06-01) -
Identification of lncRNA biomarkers in hepatocellular carcinoma by comprehensive analysis of the lncRNA-mediated ceRNA network
by: Dingde Ye, et al.
Published: (2022-08-01)